Full-Time

Specialist IS Engineer

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Mid, Senior

Hyderabad, Telangana, India

Category
IT Project Management
System Administration
IT & Security
Required Skills
SQL
Requirements
  • Doctorate Degree OR
  • Master’s degree with 4 - 6 years of experience in Computer Science, IT or related field OR
  • Bachelor’s degree with 6 - 8 years of experience in Computer Science, IT or related field OR
  • Diploma with 10 - 12 years of experience in Computer Science, IT or related field
Responsibilities
  • Drive technical discussion related to the Veeva Vault technologies related to clinical Research & Development (R&D) applications.
  • Drive database development activities per implementation project plan by working with various members of the Clinical Research Organization (CRO), and other external vendor teams.
  • Collaborate with clinical data providers (Central Laboratories, Electronic Clinical Outcome Assessments (eCOA), Interactive Response Technology (IRT), etc.) to receive data and configure transfers based on requirements.
  • Configure forms, rules, and other study items with Veeva Vault CDMS product during development and develop custom listings based on customer data cleaning requirements using SQL-based language.
  • Conduct user acceptance testing with the customer, including coordination of all feedback, resolution of issues, and acceptance of the study.
  • Support requirements gathering and specification creation process for all study integrations and release activities to ensure a smooth transition of the study to the customer.
  • Communicate potential risks and contingency plans with project management to ensure process compliance with all regulatory and Amgen procedural requirements.
  • Participate and contribute to process product or standard methodologies initiatives and support developers and testers during the project lifecycle.
  • Participate in Vault CDMS Product team discussions to convey data management activities, challenges, and end-user expectations.
  • Configure and support data ingestions (imports) into Veeva Clinical Database (CDB).
  • Define, author, and present various architecture footprints i.e. Business, Logical, Integration, Security, Infrastructure, etc.
  • Define integration design by engaging Veeva technical team.
  • Create and maintain documentation on software architecture, design, deployment, disaster recovery, and operations.
  • Identify and resolve technical challenges effectively.
  • Identify and resolve software bugs and performance issues.
  • Work closely with multi-functional teams, including product management, design, and QA, to deliver high-quality software on time.
Desired Qualifications
  • Working knowledge of clinical trial processes specifically as they relate to data collection and review.
  • Prior experience in programming languages such as (SAS, R, JSON, Python, SQL) with the ability to learn new programming languages (SQL based language).
  • Experience in Clinical teams with a focus on data management, database building, or programming (e.g., SQL, C++, JavaScript, XML).
  • End-user and/or Administrator experience with Clinical Data Capture software.
  • Understanding of SaaS/Cloud solutions and technology.
  • Experience working with system integrators for IRT, medical coding, eSource, Clinial Trial Management Systems (CTMS), Electronic Trial Master File (eTMF), and other clinical technologies.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a significant portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective therapeutic solutions and expanding its pipeline of potential new treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.